Trinity Biotech (TRIB) Beginning Cash Balance (2009 - 2024)

Trinity Biotech has disclosed Beginning Cash Balance across 16 years of filings, most recently posting $3.7 million for Q4 2024.

• In Q4 2024, Beginning Cash Balance fell 43.89% year-over-year to $3.7 million; the TTM figure through Dec 2024 stood at $3.7 million (down 43.89% YoY), while the FY2024 annual figure was $3.7 million, down 43.89% from the prior year.
• Beginning Cash Balance came in at $3.7 million for Q4 2024 at Trinity Biotech, down from $5.3 million in the prior quarter.
• In the past five years, Beginning Cash Balance ranged from a high of $32.3 million in Q2 2021 to a low of $3.7 million in Q1 2024.
• Average Beginning Cash Balance over 5 years is $16.6 million, with a median of $16.4 million recorded in 2020.
• Year-over-year, Beginning Cash Balance jumped 96.81% in 2021 and slumped 74.61% in 2023.
• Over 5 years, Beginning Cash Balance stood at $19.9 million in 2020, then soared by 38.0% to $27.5 million in 2021, then slipped by 5.7% to $25.9 million in 2022, then tumbled by 74.61% to $6.6 million in 2023, then sank by 43.89% to $3.7 million in 2024.
• Per Business Quant data, the three most recent Beginning Cash Balance figures were $3.7 million in Q4 2024, $5.3 million in Q3 2024, and $5.8 million in Q2 2024.